Irritable Bowel Syndrome News

In this video exclusive, Sabine Hazan, MD, discussed what stool says about an individual’s health, the role of the gut microbiome in overall health and things COVID-19 survivors and long-haulers need to pay attention to.

Mucosal biofilms are endoscopic features in patients with irritable bowel syndrome and ulcerative colitis with disrupted bile acid metabolism and bacterial dysbiosis, according to a study in Gastroenterology.

Evidence from a systematic review published in American Journal of Gastroenterology showed polyethylene glycol and senna were effective for the treatment of constipation.

In this video exclusive, Qi T. Yu, DO, from Loma Linda University Health, discussed how laxatives at baseline impacted the outcomes of subcutaneous Relistor in patients with advanced illness and opioid-induced constipation.

Patients with chronic constipation who received kiwi fruit, prunes and psyllium reported relief in symptoms, according to a study published in American Journal of Gastroenterology.

Trulance improved quality of life among patients with irritable bowel syndrome and chronic constipation, Greg Sayuk, MD, MPH, Washington University at St. Louis, told Healio.

In this video exclusive, Brian E. Lacy, MD, from Mayo Clinic, Jacksonville, Florida, spoke about a survey of patients with IBS with constipation in the era of COVID-19.

A FODMAP-lowering diet administered through smartphone application was superior to standard medical therapy alone in improved symptom severity among patients with irritable bowel syndrome, according to a presentation at Digestive Disease Week.

Despite ongoing COVID-19 infection control restrictions, volumes of inpatient consults for alcohol-related gastrointestinal and liver diseases had significantly decreased at the onset of the COVID-19 pandemic, but quickly returned to normal levels, according to an expert presentation during a press conference in advance of Digestive Diseases Week.

Patients with Rome IV irritable bowel syndrome had more severe symptoms with negative implications on quality of life compared with patients with Rome III IBS, according to research published in Clinical Gastroenterology and Hepatology.